Senate Delays Federal Hemp Ban to December 11, Sends Funding Bill to House 61-32. Then 90-6. Those are the numbers that matter. The Senate voted early Saturday morning to fund the federal government through December 11, and buried inside that funding bill is a one-month reprieve for the hemp industry from a ban that was set to take effect November 12.
Here’s how it happened, in order.
The Vote
The Continuing Appropriations and Extensions Act, 2027, released by the Senate Appropriations Committee, keeps the government funded at current levels through December 11 and gives lawmakers roughly ten extra weeks to finish full-year appropriations. Written into the base text, at the White House’s request, was a provision delaying most of the hemp restrictions that were scheduled to take effect November 12 under last year’s redefinition law.
Before final passage, Senators Ted Budd (R-N.C.) and Pete Ricketts (R-Neb.) forced a vote on an amendment to strip that hemp language out and let the November 12 deadline stand as written. Senator Amy Klobuchar moved to table the amendment. The motion passed 61-32, killing the Budd-Ricketts effort and preserving the delay. The full CR then passed 90-6.
The bill now goes to the House, which is out of session until the first week of September. The House already passed its own CR back on July 21 , funding the government only through December 4, with no hemp provision attached. The two chambers will need to reconcile those differences before anything reaches the president’s desk.
What’s Delayed and What Isn’t
The delay isn’t a blanket pause. It’s specific.
Products containing cannabinoids that can’t be naturally produced by the cannabis plant, the synthetic stuff, still lose federal hemp status on November 12, exactly as originally scheduled. No change there.
What moves to December 11: the redefinition of hemp from the current 0.3% delta-9 THC (dry weight) standard to a broader total-THC calculation that includes THCA, along with a new 0.4 milligram total-THC-per-container cap on finished products. That’s the provision the beverage industry, CBD manufacturers, and full-spectrum hemp companies had been lobbying hardest to delay, since it would otherwise have knocked most of their current product lines out of federal compliance overnight.
Who Was on Which Side
Budd and Ricketts argued the delay hands the hemp industry another month to sell intoxicating products that mimic marijuana, pointing to a steep rise in pediatric cannabis-poisoning ER visits. Thirty-five state attorneys general, led by Indiana’s Todd Rokita, sent a letter to congressional leadership urging them to reject the delay. CMS Administrator Mehmet Oz also came out against the Budd amendment.
On the other side: the U.S. Hemp Roundtable, the Hemp Beverage Alliance, and companies like Cornbread Hemp pushed hard for the extension, framing it as breathing room for Congress to pass a permanent regulatory fix, specifically pointing to the bipartisan Lawful Hemp Protection Act from Reps. Andy Barr and Angie Craig, which would set a national potency standard rather than a blanket ban. The White House backed the delay directly; President Trump called Budd by phone after he filed his amendment to make the administration’s case.
Senate Majority Leader John Thune’s floor coordination got the bill through despite days of internal GOP friction over the provision — Senators Mike Rounds, Jerry Moran, and Bill Cassidy had initially signaled support for the Budd amendment before the tabling vote went the other way.
What Happens Next
This is not a permanent fix. The delay runs out December 11, and Budd has already indicated he’ll bring the fight back when Congress returns. The House still has to act, and its current CR doesn’t include the hemp provision at all, so that gap gets negotiated in September.
For Virginia, the practical read is this: nothing about state-level hemp and cannabis regulation changes today. The federal delay affects the compliance timeline for interstate hemp products and the definitions VDACS and other state agencies will eventually have to align wit, but it runs on its own track from Virginia’s ongoing work, including the state’s adult-use retail framework (launching July 2027) and the pending 25:1 CBD:THC ratio litigation. Worth watching whether Barr-Craig gains traction before December, since a permanent federal standard would be the thing that actually settles what Virginia operators are building toward.
